Archives: Agenda

• What “platform firms” look like by 2030: AI-assisted review and automated workflows as the operating system, removing manual bottlenecks and partner-dependent processes.
• The next core stack: unified data as a single source of truth, portals/self-service replacing email, predictive insights becoming a standard client deliverable.
• Competitive differentiators: AI-driven client engagement, mandatory digital ID, and cyber/security standards as selection criteria—how to prioritise investments now.

Chair & moderator: Mark McNee, Commercial Director, Acting Office

• Practical AI Application: deep dives into how agentic workflows are embedded into data ingestion and reporting.
• AI that understands the engagement: how Caseware Verity connects your data, workpapers and professional judgment in one place.

• Geopolitical fragmentation and the importance of global standards.
• Technology and artificial intelligence: challenges and opportunities, AI governance.
• Attracting and retaining talent, demographic change, and “Everything Needs Accounting”.
• Business resilience, sustainable organizations and long-term value creation.

• Exploring the capability of Digital Display Labels (DDLs) and the benefits for Clinical Trial Supplies
• A demonstration of the functionality of DDLs; just in time labelling, lot & expiry update, multiple page count.
• Understanding the operational ability to securely & remotely update content & language.
• Integrating across IMP profiles, vials, bottles, blisters.

• Addressing logistical challenges in clinical trials for blood sample processing
• Implementing solutions to stabilise biomarkers at collection and simplify workflows